CT-Agent: Clinical Trial Multi-Agent with Large Language Model-based Reasoning
2404.14777
0
0
š¬
Abstract
Large Language Models (LLMs) and multi-agent systems have shown impressive capabilities in natural language tasks but face challenges in clinical trial applications, primarily due to limited access to external knowledge. Recognizing the potential of advanced clinical trial tools that aggregate and predict based on the latest medical data, we propose an integrated solution to enhance their accessibility and utility. We introduce Clinical Agent System (CT-Agent), a Clinical multi-agent system designed for clinical trial tasks, leveraging GPT-4, multi-agent architectures, LEAST-TO-MOST, and ReAct reasoning technology. This integration not only boosts LLM performance in clinical contexts but also introduces novel functionalities. Our system autonomously manages the entire clinical trial process, demonstrating significant efficiency improvements in our evaluations, which include both computational benchmarks and expert feedback.
Create account to get full access
Overview
- Large language models (LLMs) and multi-agent systems have shown impressive capabilities in natural language tasks, but face challenges in clinical trial applications due to limited access to external knowledge.
- Recognizing the potential of advanced clinical trial tools that aggregate and predict based on the latest medical data, the researchers propose an integrated solution to enhance accessibility and utility.
- They introduce Clinical Agent System (CT-Agent), a clinical multi-agent system designed for clinical trial tasks, leveraging GPT-4, multi-agent architectures, LEAST-TO-MOST, and ReAct reasoning technology.
Plain English Explanation
The paper describes a new system called CT-Agent that aims to improve the ability of AI agents to handle clinical trial tasks. Large language models and multi-agent systems have shown promise in understanding and processing natural language, but they have struggled when applied to the specific domain of clinical trials.
The researchers recognized that having access to the latest medical data could help these AI systems perform better in clinical contexts. So they developed an integrated solution that combines several advanced technologies, including the powerful GPT-4 language model, multi-agent architectures that allow different AI components to work together, and reasoning techniques like LEAST-TO-MOST and ReAct.
The result is a CT-Agent system that can autonomously manage the entire clinical trial process, from start to finish. The researchers found that this approach led to significant improvements in efficiency compared to existing methods, based on both computational benchmarks and feedback from experts in the field.
Technical Explanation
The paper introduces CT-Agent, a clinical multi-agent system designed to enhance the performance of large language models (LLMs) and multi-agent systems in clinical trial applications. The researchers recognized that the key limitation of these advanced AI systems in clinical contexts was their lack of access to the latest medical data and knowledge.
To address this, the CT-Agent system integrates several technologies, including:
- GPT-4: A powerful large language model that provides the foundation for natural language understanding and generation.
- Multi-agent architectures: Allow different AI components to work together, each specializing in a particular task or function.
- LEAST-TO-MOST: A reasoning technique that helps the system efficiently navigate the complex clinical trial process.
- ReAct reasoning: Another reasoning approach that allows the system to make decisions and take actions based on the latest medical data and knowledge.
The researchers evaluated the CT-Agent system using both computational benchmarks and expert feedback. Their results show that this integrated approach leads to significant improvements in the efficiency of clinical trial management, compared to existing methods.
Critical Analysis
The paper presents a compelling solution to the challenge of applying advanced AI systems, such as large language models and multi-agent systems, to the specific domain of clinical trials. By leveraging the latest medical data and knowledge, the CT-Agent system is able to overcome the limitations of these AI technologies in clinical contexts.
However, the paper does not discuss in detail the potential limitations or challenges of the CT-Agent system. For example, it's unclear how the system handles the dynamic and evolving nature of medical knowledge, or how it ensures the reliability and accuracy of the data it uses to make decisions.
Additionally, the paper could have explored the ethical implications of using an autonomous AI system to manage clinical trials, such as issues around transparency, accountability, and the potential for biased decision-making. These are important considerations that should be addressed as advanced AI agents are increasingly deployed in high-stakes domains like healthcare.
Conclusion
The CT-Agent system presented in this paper represents a significant step forward in the application of advanced AI technologies to clinical trial management. By integrating large language models, multi-agent architectures, and specialized reasoning techniques, the researchers have developed a solution that can autonomously handle the entire clinical trial process with improved efficiency.
This research has the potential to revolutionize the way clinical trials are conducted, making them more accessible and cost-effective. Furthermore, the CT-Agent system could serve as a foundation for developing even more capable AI agents that can assist healthcare professionals in delivering better patient outcomes.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
š¬
MedAgents: Large Language Models as Collaborators for Zero-shot Medical Reasoning
Xiangru Tang, Anni Zou, Zhuosheng Zhang, Ziming Li, Yilun Zhao, Xingyao Zhang, Arman Cohan, Mark Gerstein
0
0
Large language models (LLMs), despite their remarkable progress across various general domains, encounter significant barriers in medicine and healthcare. This field faces unique challenges such as domain-specific terminologies and reasoning over specialized knowledge. To address these issues, we propose MedAgents, a novel multi-disciplinary collaboration framework for the medical domain. MedAgents leverages LLM-based agents in a role-playing setting that participate in a collaborative multi-round discussion, thereby enhancing LLM proficiency and reasoning capabilities. This training-free framework encompasses five critical steps: gathering domain experts, proposing individual analyses, summarising these analyses into a report, iterating over discussions until a consensus is reached, and ultimately making a decision. Our work focuses on the zero-shot setting, which is applicable in real-world scenarios. Experimental results on nine datasets (MedQA, MedMCQA, PubMedQA, and six subtasks from MMLU) establish that our proposed MedAgents framework excels at mining and harnessing the medical expertise within LLMs, as well as extending its reasoning abilities. Our code can be found at https://github.com/gersteinlab/MedAgents.
6/6/2024
ArgMed-Agents: Explainable Clinical Decision Reasoning with LLM Disscusion via Argumentation Schemes
Shengxin Hong, Liang Xiao, Xin Zhang, Jianxia Chen
0
0
There are two main barriers to using large language models (LLMs) in clinical reasoning. Firstly, while LLMs exhibit significant promise in Natural Language Processing (NLP) tasks, their performance in complex reasoning and planning falls short of expectations. Secondly, LLMs use uninterpretable methods to make clinical decisions that are fundamentally different from the clinician's cognitive processes. This leads to user distrust. In this paper, we present a multi-agent framework called ArgMed-Agents, which aims to enable LLM-based agents to make explainable clinical decision reasoning through interaction. ArgMed-Agents performs self-argumentation iterations via Argumentation Scheme for Clinical Discussion (a reasoning mechanism for modeling cognitive processes in clinical reasoning), and then constructs the argumentation process as a directed graph representing conflicting relationships. Ultimately, use symbolic solver to identify a series of rational and coherent arguments to support decision. We construct a formal model of ArgMed-Agents and present conjectures for theoretical guarantees. ArgMed-Agents enables LLMs to mimic the process of clinical argumentative reasoning by generating explanations of reasoning in a self-directed manner. The setup experiments show that ArgMed-Agents not only improves accuracy in complex clinical decision reasoning problems compared to other prompt methods, but more importantly, it provides users with decision explanations that increase their confidence.
6/24/2024
šÆ
Enhancing Diagnostic Accuracy through Multi-Agent Conversations: Using Large Language Models to Mitigate Cognitive Bias
Yu He Ke, Rui Yang, Sui An Lie, Taylor Xin Yi Lim, Hairil Rizal Abdullah, Daniel Shu Wei Ting, Nan Liu
0
0
Background: Cognitive biases in clinical decision-making significantly contribute to errors in diagnosis and suboptimal patient outcomes. Addressing these biases presents a formidable challenge in the medical field. Objective: This study explores the role of large language models (LLMs) in mitigating these biases through the utilization of a multi-agent framework. We simulate the clinical decision-making processes through multi-agent conversation and evaluate its efficacy in improving diagnostic accuracy. Methods: A total of 16 published and unpublished case reports where cognitive biases have resulted in misdiagnoses were identified from the literature. In the multi-agent framework, we leveraged GPT-4 to facilitate interactions among four simulated agents to replicate clinical team dynamics. Each agent has a distinct role: 1) To make the final diagnosis after considering the discussions, 2) The devil's advocate and correct confirmation and anchoring bias, 3) The tutor and facilitator of the discussion to reduce premature closure bias, and 4) To record and summarize the findings. A total of 80 simulations were evaluated for the accuracy of initial diagnosis, top differential diagnosis and final two differential diagnoses. Results: In a total of 80 responses evaluating both initial and final diagnoses, the initial diagnosis had an accuracy of 0% (0/80), but following multi-agent discussions, the accuracy for the top differential diagnosis increased to 71.3% (57/80), and for the final two differential diagnoses, to 80.0% (64/80). Conclusions: The framework demonstrated an ability to re-evaluate and correct misconceptions, even in scenarios with misleading initial investigations. The LLM-driven multi-agent conversation framework shows promise in enhancing diagnostic accuracy in diagnostically challenging medical scenarios.
5/14/2024
š¬
New!Answering real-world clinical questions using large language model based systems
Yen Sia Low (Atropos Health, New York NY, USA), Michael L. Jackson (Atropos Health, New York NY, USA), Rebecca J. Hyde (Atropos Health, New York NY, USA), Robert E. Brown (Atropos Health, New York NY, USA), Neil M. Sanghavi (Atropos Health, New York NY, USA), Julian D. Baldwin (Atropos Health, New York NY, USA), C. William Pike (Atropos Health, New York NY, USA), Jananee Muralidharan (Atropos Health, New York NY, USA), Gavin Hui (Atropos Health, New York NY, USA, Department of Medicine, University of California, Los Angeles CA, USA), Natasha Alexander (Department of Pediatrics, The Hospital for Sick Children, Toronto ON, Canada), Hadeel Hassan (Department of Pediatrics, The Hospital for Sick Children, Toronto ON, Canada), Rahul V. Nene (Department of Emergency Medicine, University of California, San Diego CA, USA), Morgan Pike (Department of Emergency Medicine, University of Michigan, Ann Arbor MI, USA), Courtney J. Pokrzywa (Department of Surgery, Columbia University, New York NY, USA), Shivam Vedak (Center for Biomedical Informatics Research, Stanford University, Stanford CA, USA), Adam Paul Yan (Department of Pediatrics, The Hospital for Sick Children, Toronto ON, Canada), Dong-han Yao (Center for Biomedical Informatics Research, Stanford University, Stanford CA, USA), Amy R. Zipursky (Department of Pediatrics, The Hospital for Sick Children, Toronto ON, Canada), Christina Dinh (Atropos Health, New York NY, USA), Philip Ballentine (Atropos Health, New York NY, USA), Dan C. Derieg (Atropos Health, New York NY, USA), Vladimir Polony (Atropos Health, New York NY, USA), Rehan N. Chawdry (Atropos Health, New York NY, USA), Jordan Davies (Atropos Health, New York NY, USA), Brigham B. Hyde (Atropos Health, New York NY, USA), Nigam H. Shah (Atropos Health, New York NY, USA, Center for Biomedical Informatics Research, Stanford University, Stanford CA, USA), Saurabh Gombar (Atropos Health, New York NY, USA, Department of Pathology, Stanford University, Stanford CA, USA)
0
0
Evidence to guide healthcare decisions is often limited by a lack of relevant and trustworthy literature as well as difficulty in contextualizing existing research for a specific patient. Large language models (LLMs) could potentially address both challenges by either summarizing published literature or generating new studies based on real-world data (RWD). We evaluated the ability of five LLM-based systems in answering 50 clinical questions and had nine independent physicians review the responses for relevance, reliability, and actionability. As it stands, general-purpose LLMs (ChatGPT-4, Claude 3 Opus, Gemini Pro 1.5) rarely produced answers that were deemed relevant and evidence-based (2% - 10%). In contrast, retrieval augmented generation (RAG)-based and agentic LLM systems produced relevant and evidence-based answers for 24% (OpenEvidence) to 58% (ChatRWD) of questions. Only the agentic ChatRWD was able to answer novel questions compared to other LLMs (65% vs. 0-9%). These results suggest that while general-purpose LLMs should not be used as-is, a purpose-built system for evidence summarization based on RAG and one for generating novel evidence working synergistically would improve availability of pertinent evidence for patient care.
7/2/2024